Interview- Meet Our New FAS, Lisa Creary

29/10/2020

We are happy to announce that Lisa Creary joined Omixon as a Field Application Scientist effective October, 2020. In the following mini-interview Lisa talks about her passion, experiences and thoughts on HLA activities. Welcome Lisa! How did you become a scientist? My first experience of science dates back many moons...

Webinar – HLA Genotype Shapes JAK2 V617F Driven Oncogenesis

21/09/2020

Join us for a webinar with Prof. Milena Ivanova MD (Molecular Biologist, Lab Co-Director at the Dept. of Clinical Immunology, University Hospital Aleksandrovska, Sofia, Bulgaria) and Libor Kolesár (Senior Field Applications Scientist & Assay Product Manager, Omixon). HLA class I and class II alleles have been shown to...

The Complex Immunological Pathogenesis Behind COVID-19

27/04/2020

Clinicians, scientific communities, biotech companies, public health agencies alongside with governments around the world are working to support the fight against the current COVID19 pandemic. Despite these huge efforts, we do not have a detailed picture of the new coronavirus, including the immunopathogenesis of the disease. This review tries...

How Genetic Variation in the Immune System Predicts COVID-19 Disease Outcome

23/03/2020

Authors: Csaba Pal, Mate Manczinger, Attila Berces As we all know, the COVID-19 infectious disease caused by the SARS-CoV2 virus has spread globally. It is a significant and urgent medical threat with serious implications on our personal life and global economy. Therefore, it is of paramount importance to identify...

Transplantation: What Was and What is Next?

25/01/2017

118 893 33 596 15 591 These are just 3 numbers in the United States to describe transplantation in 2016. According to the annual data of UNOS (United Network for Organ Sharing): 118 893 people needed organ transplant 33 596 transplants performed in 2016 15 591 total number of donors...